Is bupropion (Wellbutrin) safe and appropriate to combine with citalopram?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Combining Bupropion (Wellbutrin) with Citalopram

Yes, bupropion can be safely combined with citalopram, and this combination is supported by both FDA drug interaction data and clinical evidence showing it is generally well-tolerated and may enhance antidepressant response.

Pharmacokinetic Interaction Profile

The FDA drug label for bupropion specifically addresses this combination and provides reassuring data 1:

  • Citalopram does NOT affect bupropion metabolism: Studies show citalopram has no impact on the pharmacokinetics of bupropion or its three metabolites
  • Bupropion modestly increases citalopram levels: Bupropion increases citalopram Cmax by 30% and AUC by 40% 1
  • Clinical significance: This modest increase is generally well-tolerated and does not require routine dose adjustment, though monitoring for citalopram-related side effects (nausea, sleep disturbances) is prudent

Clinical Evidence for Combination Therapy

Augmentation Strategy

When citalopram alone is insufficient, adding bupropion is a validated approach:

  • STAR*D trial data shows augmenting citalopram with bupropion produces similar efficacy to augmenting with buspirone or cognitive therapy 2, 3
  • Bupropion augmentation had fewer discontinuations due to adverse events (12.5%) compared to buspirone (20.6%) 3
  • A naturalistic study found combining citalopram and bupropion was superior to switching to monotherapy, with better symptom reduction (-14.8 vs -10.1 on SIGH-SAD, p<0.04) and higher remission rates (28% vs 7%, p<0.05) 4

Complementary Mechanisms

The combination offers mechanistic advantages 5:

  • Citalopram: Selective serotonin reuptake inhibition
  • Bupropion: Dopamine/norepinephrine reuptake inhibition plus nicotinic receptor antagonism
  • This dual mechanism addresses different neurotransmitter systems and may improve response in treatment-resistant depression

Specific Clinical Benefits

Bupropion is particularly beneficial for:

  • Hypersomnia, increased appetite, weight gain, and fatigue 6
  • Sexual dysfunction caused by SSRIs like citalopram 5
  • Patients with comorbid depression and need for smoking cessation 7

The combination may be prioritized when:

  • Residual symptoms persist on citalopram monotherapy
  • SSRI-induced sexual dysfunction is problematic
  • Activating properties are desired (bupropion counters SSRI-related sedation)

Safety Considerations

Seizure Risk

  • Bupropion lowers seizure threshold (0.1% risk at recommended doses) 8
  • Contraindicated in: Patients with seizure disorders, bulimia, anorexia, or abrupt alcohol/benzodiazepine withdrawal 9
  • Use with caution in: Patients with brain metastases, history of head trauma, or other seizure risk factors

Neuropsychiatric Monitoring

Both medications carry warnings about neuropsychiatric effects 8, 9:

  • Monitor for worsening depression, suicidal ideation, agitation, or hostility
  • Recent large trials (EAGLES) found no significant increase in neuropsychiatric adverse events with bupropion compared to placebo 8
  • The combination should be used cautiously in patients with active severe depression requiring close monitoring

Cardiovascular Effects

  • QTc prolongation: A cross-sectional study found no significant QTc prolongation with citalopram at therapeutic doses (≤60 mg/day), and bupropion did not affect this relationship 10
  • Monitor blood pressure and heart rate, particularly with bupropion 9

Drug-Specific Precautions

  • Avoid bupropion in: Uncontrolled hypertension, patients requiring opioid therapy (if using naltrexone-bupropion formulation)
  • Citalopram maximum dose: 40 mg/day (20 mg/day in patients >60 years or with hepatic impairment)

Practical Implementation

Starting the combination:

  1. If citalopram is already established, add bupropion starting at 150 mg once daily in the morning
  2. After 3-4 days, increase to 150 mg twice daily if tolerated (give second dose before 3 PM to minimize insomnia) 11
  3. Maximum bupropion dose: 300 mg/day in divided doses

Monitoring:

  • Assess response at 4-6 weeks (full therapeutic trial requires 4-8 weeks) 11
  • Monitor for side effects: insomnia, dry mouth, headache, nausea, agitation
  • Watch for serotonin syndrome symptoms (rare but possible with any serotonergic combination)

Common pitfalls to avoid:

  • Dosing bupropion too late in the day (causes insomnia)
  • Failing to monitor blood pressure in hypertensive patients
  • Using in patients with unrecognized eating disorders or seizure risk factors

Alternative Considerations

If the combination is not appropriate, consider 9:

  • Switching to a different SSRI or SNRI
  • Augmentation with mirtazapine (better for insomnia, decreased appetite)
  • Augmentation with aripiprazole or other atypical antipsychotics for severe depression

References

Guideline

smoking cessation, version 1.2016, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Guideline

american association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.